USO 25128
An Observational Long-Term Follow-up Study of Patients Who Received Prior Caribou Cell Therapy (LTFS)
Disease Types: CAR-T
Eligibility Requirements:
*Written informed consent (by patient or legal representative) obtained prior to study-specific activities/enrollment
*Completed a Caribou-sponsored study or was administered Caribou IP under a special access program or as part of an IIT
*Use of an effective method of birth control by women of childbearing potential and their partners and men with partners of childbearing potential (partners must also use an effective birth control method) through 12 months post IP infusion.
For more information on this trial CLICK HERE .
Available at: